chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain
Clinical narrative: Couldn't even lift arm; Pain (shooting into jaw line a couple of days ago); Heaviness; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Heaviness), LIMB DISCOMFORT (Couldn't even lift arm) and PAIN (Pain (shooting into jaw line a couple of days ago)) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced LIMB DISCOMFORT (Heaviness) and PAIN (Pain (shooting into jaw line a couple of days ago)). On 25-Mar-2021, the patient experienced LIMB DISCOMFORT (Couldn't even lift arm). The patient was treated with NAPROXEN SODIUM (ALEVE) ongoing since an unknown date for Pain, at a dose of 1 dosage form. At the time of the report, LIMB DISCOMFORT (Heaviness), LIMB DISCOMFORT (Couldn't even lift arm) and PAIN (Pain (shooting into jaw line a couple of days ago)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the patient. The patient stated that she had several Chinese herbs and turmeric.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: follow up added
Sex: F
Vaccine: COVID19
Symptoms: Chills, Exposure during pregnancy, Fatigue, Pregnancy test
Clinical narrative: pregnancy; chills in the middle of the night; really tired/ Fatigue; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnancy), FATIGUE (really tired/ Fatigue) and CHILLS (chills in the middle of the night) in a female patient of an unknown age (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 18-Feb-2021 and the estimated date of delivery was 25-Nov-2021. On 12-Mar-2021, the patient experienced FATIGUE (really tired/ Fatigue). On 13-Mar-2021, the patient experienced CHILLS (chills in the middle of the night). On 17-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (pregnancy), FATIGUE (really tired/ Fatigue) and CHILLS (chills in the middle of the night) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Pregnancy test: positive (Positive) positive pregnancy test 5 days after the first dose..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: little bit of a sore arm; itches; kind of burns; 3 inch by 3 inch red swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little bit of a sore arm), VACCINATION SITE PRURITUS (itches), VACCINATION SITE PAIN (kind of burns) and VACCINATION SITE SWELLING (3 inch by 3 inch red swelling at the injection site) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itches), VACCINATION SITE PAIN (kind of burns) and VACCINATION SITE SWELLING (3 inch by 3 inch red swelling at the injection site). On an unknown date, the patient experienced PAIN IN EXTREMITY (little bit of a sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (little bit of a sore arm), VACCINATION SITE PRURITUS (itches), VACCINATION SITE PAIN (kind of burns) and VACCINATION SITE SWELLING (3 inch by 3 inch red swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test, Vaccination site pain
Clinical narrative: Soreness at the Injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the Injection site) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 013L20A) for an unknown indication.     The patient's past medical history included Thrombocytopenic purpura (Resolved). Concurrent medical conditions included Chronic lymphocytic leukemia (partial remission).   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the Injection site). On 01-Feb-2021, VACCINATION SITE PAIN (Soreness at the Injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Mar-2021, SARS-CoV-2 antibody test: negative (Negative) Negative.         Treatment information not provided.  In Mar 2021 patient also undergone T-Cell test specific to Covid-19 which came positive.   This case was linked to MOD-2021-065382 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow-up received on 14 May 2021, investigations reported
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: Aches; Fatigue; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Aches), FATIGUE (Fatigue) and PYREXIA (low grade fever) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 025J20A) for COVID-19 vaccination.     The patient's past medical history included Idiopathic thrombocytopenic purpura (resolved) and Lymphocytic leukemia (Chronic Lymphocytic Leukemia which is in partial remission). Concomitant products included IMMUNOGLOBULINS NOS (IMMUNE GLOBULIN) for Chronic lymphocytic leukemia, PARACETAMOL (TYLENOL), Veoclexta and IBRUTINIB (IMBRUVICA) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced MYALGIA (Aches), FATIGUE (Fatigue) and PYREXIA (low grade fever). On 27-Feb-2021, MYALGIA (Aches), FATIGUE (Fatigue) and PYREXIA (low grade fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Mar-2021, SARS-CoV-2 antibody test: negative (Negative) Negative.         Treatment medication use was not provided by the reporter.  The patient got Covid-19 antibody test to check if he developed any antibodies to Covid-19. The results came back negative   The patient's immunologist recommended to get a T-cell specific test to Covid-19. The test was approved by the FDA on 05 Mar 2021. The results came back positive.   This case was linked to MOD-2021-065381 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up received and lab details were updated.
Sex: U
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: Malaise; feverish; This spontaneous case was reported by a health care professional and describes the occurrence of MALAISE (Malaise) and PYREXIA (feverish) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (Malaise) and PYREXIA (feverish). At the time of the report, MALAISE (Malaise) and PYREXIA (feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives starting all over the body from head to toe and its persisting.; continue to break out daily with new hives ranging from half a dollar to plum size; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives starting all over the body from head to toe and its persisting.) and URTICARIA (continue to break out daily with new hives ranging from half a dollar to plum size) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No medical history provided.  Concomitant products included SERTRALINE, MAGNESIUM, CYANOCOBALAMIN (COBALAMIN), OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), FAMOTIDINE (PEPCID AC), GABAPENTIN, FAMOTIDINE, ATORVASTATIN, LEVOTHYROXINE, ATENOLOL, LOSARTAN, METFORMIN and INSULIN HUMAN (HUMULIN NORMAL) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced URTICARIA (hives starting all over the body from head to toe and its persisting.) and URTICARIA (continue to break out daily with new hives ranging from half a dollar to plum size). At the time of the report, URTICARIA (hives starting all over the body from head to toe and its persisting.) had not resolved and URTICARIA (continue to break out daily with new hives ranging from half a dollar to plum size) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Pain in extremity, Peripheral swelling
Clinical narrative: pain in her armpit; swelling in left arm pit; sore; This spontaneous case was reported by a pharmacist and describes the occurrence of AXILLARY PAIN (pain in her armpit), PERIPHERAL SWELLING (swelling in left arm pit) and PAIN IN EXTREMITY (sore) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced AXILLARY PAIN (pain in her armpit), PERIPHERAL SWELLING (swelling in left arm pit) and PAIN IN EXTREMITY (sore). At the time of the report, AXILLARY PAIN (pain in her armpit), PERIPHERAL SWELLING (swelling in left arm pit) and PAIN IN EXTREMITY (sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included Testosterone low, Lactose intolerant, Irritable bowel syndrome, High cholesterol and Sleep difficult (trouble sleeping). Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), FINASTERIDE, LINACLOTIDE (LINZESS), TEMAZEPAM and CLOMIPHENE CITRATE for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include Linzess, ,Crestor (5 mg daily), clomid citrate (25 mg every other day), finasteride (0.125 mg daily) and temazepam (30 mg twice a week).   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up contains no new information.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Urticaria
Clinical narrative: hives; Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 infection) and URTICARIA (hives) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Ear infection.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced COVID-19 (Covid-19 infection). On 24-Mar-2021, the patient experienced URTICARIA (hives). The patient was treated with CORTICOSTEROIDS (STEROIDS) for Hives, at an unspecified dose and frequency. At the time of the report, COVID-19 (Covid-19 infection) and URTICARIA (hives) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, SARS-CoV-2 test: positive (Positive) diagnosed with  Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain
Clinical narrative: Diarrhea off and on; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea off and on) and PAIN (Achiness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 010M20A) for COVID-19 vaccination.     No medical history provided.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced DIARRHOEA (Diarrhea off and on) and PAIN (Achiness). At the time of the report, DIARRHOEA (Diarrhea off and on) and PAIN (Achiness) outcome was unknown.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure via breast milk
Clinical narrative: Vaccine exposure via breast milk; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Apr-2021 and was forwarded to Moderna on 01-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy on 27-Dec-2013, Pregnancy on 16-Sep-2019 and Anemia in January 2018. Previously administered products included for Product used for unknown indication: Nicotine from January 2000 to January 2011.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk). At the time of the report, EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Pain in extremity, Pyrexia
Clinical narrative: pain in her arm; feel like wet rag; fever in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm), DISCOMFORT (feel like wet rag) and PYREXIA (fever in her arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm), DISCOMFORT (feel like wet rag) and PYREXIA (fever in her arm). At the time of the report, PAIN IN EXTREMITY (pain in her arm), DISCOMFORT (feel like wet rag) and PYREXIA (fever in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment were provided No concomitant were provided
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Tingling in the face; numbness; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the face) and HYPOAESTHESIA (numbness) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No medical history provided.  Concomitant products included VITAMINS NOS, ATORVASTATIN CALCIUM (LIPITOR) and DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PARAESTHESIA (Tingling in the face) and HYPOAESTHESIA (numbness). At the time of the report, PARAESTHESIA (Tingling in the face) and HYPOAESTHESIA (numbness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Erythema, Lethargy, Pain in extremity, Pyrexia
Clinical narrative: lethargic; burning pain in armpit; redness if fading; large red spot on her arm 2 inches below the shot; hard little lump; slight low grade fever; arm was very sore; soreness in arm after first dose; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (soreness in arm after first dose), LETHARGY (lethargic), BURNING SENSATION (burning pain in armpit), ERYTHEMA (redness if fading) and VACCINATION SITE ERYTHEMA (large red spot on her arm 2 inches below the shot) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included SUMATRIPTAN SUCCINATE (IMITREX DF), OMEPRAZOLE and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm after first dose). On 29-Mar-2021, the patient experienced LETHARGY (lethargic), BURNING SENSATION (burning pain in armpit), ERYTHEMA (redness if fading), VACCINATION SITE ERYTHEMA (large red spot on her arm 2 inches below the shot), VACCINATION SITE SWELLING (hard little lump), PYREXIA (slight low grade fever) and PAIN IN EXTREMITY (arm was very sore). At the time of the report, PAIN IN EXTREMITY (soreness in arm after first dose), LETHARGY (lethargic), BURNING SENSATION (burning pain in armpit), ERYTHEMA (redness if fading), VACCINATION SITE ERYTHEMA (large red spot on her arm 2 inches below the shot), VACCINATION SITE SWELLING (hard little lump), PYREXIA (slight low grade fever) and PAIN IN EXTREMITY (arm was very sore) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-065420 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065420:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: lethargic; burning pain in armpit; redness if fading; large red spot on her arm 2 inches below the shot; hard little lump; slight low grade fever; arm was very sore; soreness in arm after first dose; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (soreness in arm after first dose), LETHARGY (lethargic), BURNING SENSATION (burning pain in armpit), ERYTHEMA (redness if fading) and VACCINATION SITE ERYTHEMA (large red spot on her arm 2 inches below the shot) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included SUMATRIPTAN SUCCINATE (IMITREX DF), OMEPRAZOLE and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm after first dose). On 29-Mar-2021, the patient experienced LETHARGY (lethargic), BURNING SENSATION (burning pain in armpit), ERYTHEMA (redness if fading), VACCINATION SITE ERYTHEMA (large red spot on her arm 2 inches below the shot), VACCINATION SITE SWELLING (hard little lump), PYREXIA (slight low grade fever) and PAIN IN EXTREMITY (arm was very sore). At the time of the report, PAIN IN EXTREMITY (soreness in arm after first dose), LETHARGY (lethargic), BURNING SENSATION (burning pain in armpit), ERYTHEMA (redness if fading), VACCINATION SITE ERYTHEMA (large red spot on her arm 2 inches below the shot), VACCINATION SITE SWELLING (hard little lump), PYREXIA (slight low grade fever) and PAIN IN EXTREMITY (arm was very sore) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-065420 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-065420:
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hypoaesthesia oral, Lip swelling, Pain, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Lips are numb), THROAT TIGHTNESS (throat tightened up), LIP SWELLING (her lips swollen up like she had bad Botox), FEELING HOT (she felt hot all over (she felt like she drank the contrast prior to a scan)) and PAIN (pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included EZETIMIBE (ZETIA) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (Lips are numb), THROAT TIGHTNESS (throat tightened up), LIP SWELLING (her lips swollen up like she had bad Botox), FEELING HOT (she felt hot all over (she felt like she drank the contrast prior to a scan)), PAIN (pain) and PYREXIA (fever). At the time of the report, HYPOAESTHESIA ORAL (Lips are numb) had not resolved and THROAT TIGHTNESS (throat tightened up), LIP SWELLING (her lips swollen up like she had bad Botox), FEELING HOT (she felt hot all over (she felt like she drank the contrast prior to a scan)), PAIN (pain) and PYREXIA (fever) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. Treatment information was unknown. It was reported that the family doctor told the patient not to get the second dose. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up information was received from the initial reporter: The reporter contact details were added.
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Lips are numb), THROAT TIGHTNESS (throat tightened up), LIP SWELLING (her lips swollen up like she had bad Botox), FEELING HOT (she felt hot all over (she felt like she drank the contrast prior to a scan)) and PAIN (pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included EZETIMIBE (ZETIA) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (Lips are numb), THROAT TIGHTNESS (throat tightened up), LIP SWELLING (her lips swollen up like she had bad Botox), FEELING HOT (she felt hot all over (she felt like she drank the contrast prior to a scan)), PAIN (pain) and PYREXIA (fever). At the time of the report, HYPOAESTHESIA ORAL (Lips are numb) had not resolved and THROAT TIGHTNESS (throat tightened up), LIP SWELLING (her lips swollen up like she had bad Botox), FEELING HOT (she felt hot all over (she felt like she drank the contrast prior to a scan)), PAIN (pain) and PYREXIA (fever) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date. Treatment information was unknown. It was reported that the family doctor told the patient not to get the second dose. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up information was received from the initial reporter: The reporter contact details were added.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pain
Clinical narrative: Intense body pain; Diarrhea; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Intense body pain), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history provided.     On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN (Intense body pain), DIARRHOEA (Diarrhea) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Intense body pain), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Pyrexia, Rash, Rash pruritic
Clinical narrative: itchy area; feverish area; large pink area; itch; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), RASH PRURITIC (itchy area), PRURITUS (itch), PYREXIA (feverish area) and RASH (large pink area) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 010A21A) for COVID-19 vaccination.     No medical history provided.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (sore arm). On 31-Mar-2021, the patient experienced PRURITUS (itch). On 01-Apr-2021, the patient experienced RASH PRURITIC (itchy area). 01-Apr-2021, the patient experienced PYREXIA (feverish area) and RASH (large pink area). On 30-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, RASH PRURITIC (itchy area), PRURITUS (itch), PYREXIA (feverish area) and RASH (large pink area) outcome was unknown.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Impaired work ability
Clinical narrative: unable to work; feeling extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (unable to work) and FATIGUE (feeling extremely tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history provided.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced IMPAIRED WORK ABILITY (unable to work). 17-Mar-2021, the patient experienced FATIGUE (feeling extremely tired). At the time of the report, IMPAIRED WORK ABILITY (unable to work) and FATIGUE (feeling extremely tired) outcome was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Insomnia, Malaise, Myalgia, Nausea
Clinical narrative: Nausea; Feeling unwell; Weak; Unable to sleep; Aches all over her body; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell), ASTHENIA (Weak), INSOMNIA (Unable to sleep), MYALGIA (Aches all over her body) and NAUSEA (Nausea) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 30-Mar-2021, the patient experienced MALAISE (Feeling unwell), ASTHENIA (Weak), INSOMNIA (Unable to sleep) and MYALGIA (Aches all over her body). On 31-Mar-2021, the patient experienced NAUSEA (Nausea). At the time of the report, MALAISE (Feeling unwell), ASTHENIA (Weak), INSOMNIA (Unable to sleep), MYALGIA (Aches all over her body) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included generic painkiller. No concomitant medication  were given
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: "flu shot" side effects; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS ("flu shot" side effects) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 031A21A) for COVID-19 vaccination.     Concomitant products included METOPROLOL for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS ("flu shot" side effects). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and Aspirin at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS ("flu shot" side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications: Aleeve and Aspirin Dose 2 Adverse events will  be submitted in a separate case.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Felt very tired since last night; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt very tired since last night) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Tetracycline allergy) and Multiple sclerosis since 28-Jun-1977. Concomitant products included CALCIUM, VITAMIN D NOS, ALENDRONATE SODIUM (FOSAMAX) and ANASTROZOLE (ARIMIDEX) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Felt very tired since last night). On 01-Apr-2021, FATIGUE (Felt very tired since last night) had resolved.            No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Follow up received on 14-May-2021 included patient details, past medical history, additional concomitant medications, outcome of event with stop date.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pyrexia
Clinical narrative: Body pain; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body pain), PYREXIA (Fever) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood cholesterol and Blood pressure.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced MYALGIA (Body pain), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, MYALGIA (Body pain), PYREXIA (Fever) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Vaccination error (missed 2nd dose); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Vaccination error (missed 2nd dose)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Vaccination error (missed 2nd dose)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Vaccination error (missed 2nd dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 11-Dec-2020 and the estimated date of delivery was 17-Sep-2021. On 01-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifteenth week of the pregnancy.  On 01-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment medications were provided.  Date of positive pregnancy test was reported as 02-Jan-2021. Estimated date of conception reported was 19-Dec-2020.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Discomfort, Myalgia, Pain, Pain in extremity
Clinical narrative: dull and goes on and off and is only in the arm between elbow and wrist; muscle soreness; leg pain also started on 30Mar2021; lower back ache; tenderness in the left arm for 4 days; lower back pain; pain in right limb and buttocks with a little bit of pain on left side but more on the right side; soreness inthe left arm; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back pain), PAIN (pain in right limb and buttocks with a little bit of pain on left side but more on the right side), PAIN IN EXTREMITY (soreness inthe left arm), PAIN IN EXTREMITY (leg pain also started on 30Mar2021) and BACK PAIN (lower back ache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included SALBUTAMOL SULFATE (INHALERIN) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced BACK PAIN (lower back pain), PAIN (pain in right limb and buttocks with a little bit of pain on left side but more on the right side), PAIN IN EXTREMITY (soreness inthe left arm), BACK PAIN (lower back ache) and TENDERNESS (tenderness in the left arm for 4 days). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (leg pain also started on 30Mar2021) and MYALGIA (muscle soreness). On an unknown date, the patient experienced DISCOMFORT (dull and goes on and off and is only in the arm between elbow and wrist). The patient was treated with IBUPROFEN ongoing since an unknown date for Fever and Chills, at an unspecified dose and frequency. On 27-Mar-2021, PAIN IN EXTREMITY (soreness inthe left arm) and TENDERNESS (tenderness in the left arm for 4 days) had resolved. At the time of the report, BACK PAIN (lower back pain), PAIN (pain in right limb and buttocks with a little bit of pain on left side but more on the right side), PAIN IN EXTREMITY (leg pain also started on 30Mar2021), BACK PAIN (lower back ache), MYALGIA (muscle soreness) and DISCOMFORT (dull and goes on and off and is only in the arm between elbow and wrist) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       CONCOMINANT DRUG WERE NOT USED.  IBUPROFEN WAS USED AS TREATMENT DRUG, LAB DATA AND ALLERGIES WAS NOT GIVEN
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: dull and goes on and off and is only in the arm between elbow and wrist; muscle soreness; leg pain also started on 30Mar2021; lower back ache; tenderness in the left arm for 4 days; lower back pain; pain in right limb and buttocks with a little bit of pain on left side but more on the right side; soreness inthe left arm; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (lower back pain), PAIN (pain in right limb and buttocks with a little bit of pain on left side but more on the right side), PAIN IN EXTREMITY (soreness inthe left arm), PAIN IN EXTREMITY (leg pain also started on 30Mar2021) and BACK PAIN (lower back ache) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included SALBUTAMOL SULFATE (INHALERIN) for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced BACK PAIN (lower back pain), PAIN (pain in right limb and buttocks with a little bit of pain on left side but more on the right side), PAIN IN EXTREMITY (soreness inthe left arm), BACK PAIN (lower back ache) and TENDERNESS (tenderness in the left arm for 4 days). On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (leg pain also started on 30Mar2021) and MYALGIA (muscle soreness). On an unknown date, the patient experienced DISCOMFORT (dull and goes on and off and is only in the arm between elbow and wrist). The patient was treated with IBUPROFEN ongoing since an unknown date for Fever and Chills, at an unspecified dose and frequency. On 27-Mar-2021, PAIN IN EXTREMITY (soreness inthe left arm) and TENDERNESS (tenderness in the left arm for 4 days) had resolved. At the time of the report, BACK PAIN (lower back pain), PAIN (pain in right limb and buttocks with a little bit of pain on left side but more on the right side), PAIN IN EXTREMITY (leg pain also started on 30Mar2021), BACK PAIN (lower back ache), MYALGIA (muscle soreness) and DISCOMFORT (dull and goes on and off and is only in the arm between elbow and wrist) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       CONCOMINANT DRUG WERE NOT USED.  IBUPROFEN WAS USED AS TREATMENT DRUG, LAB DATA AND ALLERGIES WAS NOT GIVEN
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Psoriasis
Clinical narrative: psoriasis flared up/psoriasis flared up even more; itching and having all the stuff; I've never had so many plaques before; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (psoriasis flared up/psoriasis flared up even more), PRURITUS (itching and having all the stuff) and PSORIASIS (I've never had so many plaques before) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Psoriasis. Concurrent medical conditions included Blood pressure high. Concomitant products included LISINOPRIL for Blood pressure high.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PSORIASIS (psoriasis flared up/psoriasis flared up even more), PRURITUS (itching and having all the stuff) and PSORIASIS (I've never had so many plaques before). At the time of the report, PSORIASIS (psoriasis flared up/psoriasis flared up even more), PRURITUS (itching and having all the stuff) and PSORIASIS (I've never had so many plaques before) outcome was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Fatigue, Pyrexia
Clinical narrative: no appetite; no energy; little tired; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ASTHENIA (no energy), FATIGUE (little tired), CHILLS (chills) and PYREXIA (fever) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (oesophageal) and Gout. Concurrent medical conditions included Blood pressure high. Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR), ALLOPURINOL, AMLODIPINE and OMEPRAZOLE for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (no energy), FATIGUE (little tired), CHILLS (chills) and PYREXIA (fever). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. On 15-Mar-2021, DECREASED APPETITE (no appetite), ASTHENIA (no energy), FATIGUE (little tired), CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2020, SARS-CoV-2 test: positive (Positive) he had COVID in March 2020.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: no appetite; no energy; little tired; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (no appetite), ASTHENIA (no energy), FATIGUE (little tired), CHILLS (chills) and PYREXIA (fever) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (oesophageal) and Gout. Concurrent medical conditions included Blood pressure high. Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR), ALLOPURINOL, AMLODIPINE and OMEPRAZOLE for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), ASTHENIA (no energy), FATIGUE (little tired), CHILLS (chills) and PYREXIA (fever). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. On 15-Mar-2021, DECREASED APPETITE (no appetite), ASTHENIA (no energy), FATIGUE (little tired), CHILLS (chills) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2020, SARS-CoV-2 test: positive (Positive) he had COVID in March 2020.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.